We had the pleasure of working with FairJourney Biologics to obtain highly selective antibodies, a task that was anticipated to be particularly challenging. Remarkably, they succeeded in obtaining these antibodies within a short timeframe and have completed three independent difficult targets with exceptional outcomes. Their team, comprised of highly skilled technicians, provided invaluable guidance and optimization throughout each project. The workflow was seamless, with comprehensive data provided at every stage. We unequivocally regard FairJourney Biologics as the premier partner for acquiring antibodies for complex applications.

Takayuki Tatamiya

Director. Daiichi Sankyo Co., Ltd.

FairJourney Biologics has been a valuable CRO to Paragon Therapeutics since foundation. In addition to their renowned expertise in discovery and engineering of antibodies, their production and biophysical characterization services enable a smooth progress and completion of programs. The FJB team has generated comprehensive and high-quality data packages, has proven to be flexible and consistently delivers results on time, greatly supporting Paragon's research pipeline.

Paragon Therapeutics

“FairJourney Biologics was founded by a group of scientists that have a significant track record in generating therapeutic antibodies to industry standards. They have consistently impressed us with their speed and expertise.”

Mark Throsby

CSO, Merus

“I had the opportunity to work with FairJourney Biologics since last year and I am impressed by the skills and speed the different projects are delivered. I was personally involved in a project in summer 2013 in which we pulled out together 121 leads of highly specific antibodies in just 3 days. Moreover, the whole teams respires such a enthusiasm that it is a pleasure to work with FairJourney Biologics and I can recommend them to anyone looking for desired new antibodies.”

John Wijdenes

Mabdesign and CEOand consultant, AD&T consultancy

“FairJourney Biologics has demonstrated the capacity to deliver high quality antibody engineering services. The team is very experienced in phage display for the discovery of antibodies from rodent immune repertoires for diagnostic and therapeutic applications. Humanization is performed by affinity driven selections of libraries to avoid loss in potency. Desired specificity and optimal affinities can be achieved by applying appropriate selection methods thereby delivering leads useful for the development of highly specific and sensitive diagnostic assays. The outstanding track record of its research team, has enable the company to provide us with new antibodies with excellent characteristics.”

Hans de Haard

CSO, argenx

“Capella Bioscience is happy with the partnership with FairJourney Biologics for being capital efficient. Such a big antibody discovery team gives us the peace of mind, knowing that they have enough expertize to work with us.”

Steve Holmes

COO, Capella Bioscience

“FairJourney Biologics generated a comprehensive data package for a Viridian project, whereby they expressed, purified and characterized 17 lead antibody constructs. The characterization included biophysical properties, accelerated stability, solubility assessment, self-association potential, affinity determination and epitope binning. In addition, cell-based assays were developed to assess the functional potency of the lead molecules. The production and characterization were conducted in record time and enabled prioritization of top leads to progress towards manufacturing cell line generation. The FairJourney team was very responsive to our needs, provided helpful technical advice where needed, and was a pleasure to work with.”

Vahe Bedian

Viridian Therapeutics